0 CHECKOUT

PRODUCT FILTERS

REGION

78
27
18
14
10

COUNTRY

27
4
2
2
1

CATEGORIES

  • 374
  • 56
  • 40
  • 36
  • 14
  • 13
  • 11
  • 11
  • 10
  • 9
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

23
320
413
569

PUBLISHED

5
33
90
569

PRODUCT TYPE

354
187
20
5
1
1
1

Search for: "Breast Cancer Therapy Area Pipeline Report"

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence

Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence Summary Breast cancer, a malignant neoplasm, is the...

Published:  December 2015
Price:  From

Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence

Breast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly prevalent....

Published:  February 2016
Price:  From

US Breast Cancer Therapy Market Opportunity Analysis

Breast cancer is a type of malignancy that affects breast tissue and its incidences are increasing across the globe. It is also one of the most common cancers in American women which cause high morbidity...

Published:  July 2015
Price:  From

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

The leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance...

Published:  June 2014
Price:  From

Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016

“Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2016” provides comprehensive insights about the treatment landscape across this indication. This report...

Published:  July 2016
Price:  From

Metastatic Breast Cancer - Pipeline Review, H1 2016

Metastatic Breast Cancer - Pipeline Review, H1 2016 Summary ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape. The report...

Published:  May 2016
Price:  From

Metastatic Breast Cancer - Pipeline Review, H2 2015

Metastatic Breast Cancer - Pipeline Review, H2 2015 Summary The report ‘Metastatic Breast Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein Four are aimed at improving...

Published:  October 2013
Price:  From

Metastatic Breast Cancer - Pipeline Review, H1 2015

Metastatic Breast Cancer - Pipeline Review, H1 2015 Summary the, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline. This...

Published:  June 2015
Price:  From

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  August 2016
Price:  From

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

Published:  April 2013
Price:  From

Cancer Gene Therapy Market Analysis

The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases The initial studies of gene...

Published:  March 2014
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  August 2016
Price:  From

Global & USA Cancer Immunotherapy Market Analysis to 2020 - Updated Edition

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint...

Published:  July 2016
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  August 2016
Price:  From

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

Published:  January 2013
Price: 

Mammography World Markets

Breast cancer is the most common type of cancer in women, affecting one in eight during their lives Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast...

Published:  December 2012
Price:  From

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

Published:  March 2013
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From
Loading Indicator

Our Clients

  • Innocent Drinks Ltd.
  • Groupe Danone
  • Cisco Systems, Inc.
  • The World Bank Group
  • Swarovski AG
  • Owens Corning Corporation
  • Swiss Reinsurance Company Ltd.